Gab 4 inhibitors are a class of chemical compounds designed to interfere with the function of the Gab 4 protein, a member of the Grb2-associated binder (Gab) family of scaffold proteins. These proteins play a crucial role in intracellular signaling pathways, particularly those involving receptor tyrosine kinases (RTKs). Gab 4, like other members of its family, serves as a docking platform for various signaling molecules, facilitating the assembly of signaling complexes that propagate cellular signals from the cell membrane to the interior. The inhibition of Gab 4 can disrupt these signaling pathways, thereby modulating downstream cellular processes such as proliferation, differentiation, and migration. Structurally, Gab 4 inhibitors often feature molecular frameworks designed to bind specific domains of the Gab 4 protein, preventing its interaction with other signaling proteins or hindering its ability to localize at the plasma membrane.
Gab 4 inhibitors typically target specific sites on the Gab 4 protein to reduce its activity, often focusing on key phosphorylation sites or binding domains that are critical for its role in signal transduction. These compounds may act by competing with Gab 4's natural binding partners, thus blocking the assembly of necessary signaling complexes. In some cases, Gab 4 inhibitors may also interfere with the post-translational modifications of the protein, such as phosphorylation, that are essential for its function. Given that Gab 4 participates in various signaling pathways, its inhibition can influence multiple biological processes simultaneously, making these inhibitors valuable tools for studying the intricacies of cellular signaling networks and the role of Gab 4 in cellular homeostasis. Additionally, Gab 4 inhibitors offer a way to dissect the specific molecular interactions involving Gab 4 in the context of complex signaling cascades.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
As an EGFR inhibitor, gefitinib could downregulate signaling pathways that lead to the expression of GAB family proteins. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $85.00 $132.00 $287.00 $495.00 $3752.00 | 42 | |
Erlotinib targets the EGFR tyrosine kinase, potentially impacting the expression of downstream signaling proteins such as GAB. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $412.00 | 32 | |
Lapatinib inhibits the tyrosine kinase domains of EGFR and HER2, which may affect GAB protein expression indirectly. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor, which could disrupt the PI3K/AKT pathway and the expression of associated adapter proteins. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is another PI3K inhibitor that might suppress the expression of proteins in the PI3K/AKT signaling pathway. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can change gene expression patterns, potentially affecting GAB protein expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Binds to DNA and inhibits RNA synthesis by RNA polymerase, potentially decreasing transcription of genes like GAB. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits eukaryotic protein synthesis, potentially reducing the overall production of GAB proteins. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, affecting protein synthesis regulation, which could suppress the expression of GAB proteins. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Sorafenib is a multikinase inhibitor that can interfere with several signaling pathways, potentially affecting GAB protein expression. | ||||||